Hospital Regional Universitario de Málaga-ko ikertzaileekin lankidetzan egindako argitalpenak (23)

2022

  1. Acceleration of the DNA methylation clock among lynch syndrome-associated mutation carriers

    BMC medical genomics, Vol. 15, Núm. 1, pp. 45

2021

  1. Deletion of the Wilms’ Tumor Suppressor Gene in the Cardiac Troponin-T Lineage Reveals Novel Functions of WT1 in Heart Development

    Frontiers in Cell and Developmental Biology, Vol. 9

  2. Lymphocyte Profile and Immune Checkpoint Expression in Drug-Induced Liver Injury: An Immunophenotyping Study

    Clinical Pharmacology and Therapeutics, Vol. 110, Núm. 6, pp. 1604-1612

2017

  1. Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study

    Cytotherapy, Vol. 19, Núm. 8, pp. 927-936

  2. Gene therapy with mesenchymal stem cells expressing IFN-ß ameliorates neuroinflammation in experimental models of multiple sclerosis

    British Journal of Pharmacology, Vol. 174, Núm. 3, pp. 238-253

2010

  1. CD40: Novel association with crohn's disease and replication in multiple sclerosis susceptibility

    PLoS ONE, Vol. 5, Núm. 7, pp. 1-4

2009

  1. Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus

    Clinical and Experimental Rheumatology

  2. Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans

    Journal of Clinical Investigation, Vol. 119, Núm. 4, pp. 911-923

  3. No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus

    Lupus, Vol. 18, Núm. 3, pp. 230-234

  4. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk

    Annals of the Rheumatic Diseases, Vol. 68, Núm. 11, pp. 1746-1753

2008

  1. Study of two polymorphisms of the MHC2TA gene with systemic lupus erythematosus [1]

    Rheumatology

2007

  1. Association of a CD24 gene polymorphism with susceptibility to systemic lupus erythematosus

    Arthritis and Rheumatism, Vol. 56, Núm. 9, pp. 3080-3086

  2. MYO9B gene polymorphisms are associated with autoimmune diseases in Spanish population

    Human Immunology, Vol. 68, Núm. 7, pp. 610-615

  3. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus

    Arthritis and Rheumatism, Vol. 56, Núm. 4, pp. 1234-1241

2006

  1. Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus

    Genes and Immunity, Vol. 7, Núm. 5, pp. 433-436

  2. No primary association of MICA polymorphism with systemic lupus erythematosus

    Rheumatology, Vol. 45, Núm. 9, pp. 1096-1100

  3. Study of a functional polymorphism in the p53 gene in systemic lupus erythematosus: Lack of replication in a Spanish population

    Lupus, Vol. 15, Núm. 10, pp. 658-661

  4. Study of the role of functional variants of SLC22A4, RUNX1 and SUMO4 in systemic lupus erythematosus

    Annals of the Rheumatic Diseases, Vol. 65, Núm. 6, pp. 791-795

2004

  1. Systemic lupus erythematosus in southern Spain: A comparative clinical and genetic study between Caucasian and Gypsy patients

    Lupus, Vol. 13, Núm. 12, pp. 934-940

2003

  1. Inducible nitric oxide synthase promoter polymorphism in human brucellosis

    Microbes and Infection, Vol. 5, Núm. 13, pp. 1165-1169